| Rwanda Bank of Kigali’s $67.5 mln cash call gets 108 pct subscription rate
Bank of Kigali, Rwanda reported last week Friday that its 60 billion francs ($67.50 million) rights issue was 108% subscribed. The lender, which is Rwanda’s biggest by assets, offered one new share for every three held, issuing a total of 222.22 million shares, which will be listed domestically and on the Nairobi bourse.
DRC Congo approves clinical trials for Ebola treatments
The Health ministry, Congo authorised clinical trials for four experimental Ebola treatments, which will allow researchers to collect valuable data about their effectiveness. Health workers have already administered therapeutic treatments to more than 150 Ebola patients since August in an effort to contain the worst of Democratic Republic of Congo’s 10 outbreaks of the hemorrhagic fever since 1976 until now doctors have decided which treatment to use on a case-by-case basis. In the clinical trial, the choice of treatment will now be randomised. Treatment will still be free of charge. Information about the effectiveness of the treatments obtained during the clinical trial will allow for the development of these treatments on a wider scale to save more lives.
Zambia Zambia’s copper output up 10.4 year/year in September
Zambia’s annual copper output rose 10.4 percent in September 2018 to 631,359 tonnes according to the central bank in Africa’s second-biggest producer of the industrial metal. Some mining companies operating in Zambia include NFC Africa, majority owned by China Non-ferrous Metals Company Limited (CNMC), Canada’s First Quantum Minerals, Glencore, Barrick Gold and Vedanta Resources. |